PPARG and Alzheimer disease: The anti-inflammatory effects of many NSAIDs are dependent upon COX-2 inhibition or PPARγ activation (Jiang et al., 1998; Zarghi and Arfaei, 2011), suggesting that alterations in these pathways could be involved in the chronic neuroinflammation associated with AD.